Department of Medicine, Children's Hospital, Boston, Massachusetts, USA.
J Virol. 2013 Apr;87(8):4738-50. doi: 10.1128/JVI.03531-12. Epub 2013 Feb 13.
A comparative evaluation of the immunity stimulated with a vaccine regimen that includes simian immunodeficiency virus (SIV), interleukin 2 (IL-2), and IL-15 DNAs, recombinant modified vaccinia virus Ankara (rMVA), and inactivated SIVmac239 particles administered into the oral and nasal cavities, small intestine, and vagina was carried out in female rhesus macaques to determine the best route to induce diverse anti-SIV immunity that may be critical to protection from SIV infection and disease. All four immunizations generated mucosal SIV-specific IgA. Oral immunization was as effective as vaginal immunization in inducing SIV-specific IgA in vaginal secretions and generated greater IgA responses in rectal secretions and saliva samples compared to the other immunization routes. All four immunizations stimulated systemic T-cell responses against Gag and Env, albeit to a different extent, with oral immunization providing greater magnitude and nasal immunization providing wider functional heterogeneity. SIV-specific T cells producing gamma interferon (IFN-γ) dominated these responses. Limited levels of SIV-specific IgG antibodies were detected in plasma samples, and no SIV-specific IgG antibodies were detected in secretions. Vaccination also induced CD4(+) and CD8(+) T-cell responses in the rectal and vaginal mucosa with greater functional heterogeneity than in blood samples. Rectal T-cell responses were significantly greater in the orally vaccinated animals than in the other animals. The most balanced, diverse, and higher-magnitude vaginal T-cell responses were observed after intestinal vaccination. Significantly higher CD8(+) granzyme B-positive T-cell responses were observed systemically after intestinal vaccination and in rectal cells after oral immunization. The majority of SIV-specific T cells that produced granzyme B did not produce cytokines. Of the immunization routes tested, oral vaccination provided the most diverse and significant response to the vaccine.
在雌性恒河猴中进行了一项研究,评估了包括猴免疫缺陷病毒(SIV)、白细胞介素 2(IL-2)、白细胞介素 15 (IL-15)DNA、重组改良安卡拉痘苗病毒(rMVA)和失活的 SIVmac239 颗粒的疫苗方案刺激的免疫反应,这些疫苗通过口腔和鼻腔、小肠和阴道接种。该研究旨在确定诱导多样化的抗 SIV 免疫反应的最佳途径,这种免疫反应对于预防 SIV 感染和疾病可能至关重要。所有四种免疫接种都产生了黏膜 SIV 特异性 IgA。与其他免疫途径相比,口腔免疫接种在诱导阴道分泌物中的 SIV 特异性 IgA 方面与阴道免疫接种同样有效,并在直肠分泌物和唾液样本中产生了更大的 IgA 反应。所有四种免疫接种都刺激了针对 Gag 和 Env 的系统 T 细胞反应,尽管程度不同,口腔免疫接种提供了更大的幅度,而鼻腔免疫接种提供了更广泛的功能异质性。产生伽马干扰素(IFN-γ)的 SIV 特异性 T 细胞主导了这些反应。在血浆样本中检测到有限水平的 SIV 特异性 IgG 抗体,在分泌物中未检测到 SIV 特异性 IgG 抗体。疫苗接种还诱导了直肠和阴道黏膜中的 CD4(+)和 CD8(+) T 细胞反应,其功能异质性大于血液样本。与其他动物相比,经口接种的动物的直肠 T 细胞反应显著更高。肠道接种后观察到最平衡、多样化和高幅度的阴道 T 细胞反应。肠道接种后系统性地观察到更高的 CD8(+)颗粒酶 B 阳性 T 细胞反应,而口腔免疫接种后直肠细胞中观察到更高的 CD8(+)颗粒酶 B 阳性 T 细胞反应。产生颗粒酶 B 的大多数 SIV 特异性 T 细胞不产生细胞因子。在测试的免疫途径中,口服接种提供了对疫苗的最多样化和最显著的反应。